We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Monday broker round-up

Mon, 17th May 2021 14:38

(Sharecast News) - Diploma: Numis upgrades to add with a target price of 3,250p.

Marshalls: Berenberg reiterates hold with a target price of 790p.

Sabre Insurance Group: Berenberg reiterates hold with a target price of 257p.

Cerillion: Canaccord reiterates buy with a target price of 665p.

Sage: Canaccord reiterates buy with a target price of 700p.

Diploma: Jefferies reiterates hold with a target price of 2,300p.

Vistry Group: Jefferies reiterates buy with a target price of 1,484p.

Diageo: Goldman Sachs reiterates buy with a target price of 3,800p.

AstraZeneca: Deutsche Bank reiterates buy with a target price of 10,200p.

Sage: JP Morgan upgrades to neutral with a target price of 630p.

Just Eat: JP Morgan reiterates neutral with a target price of 9,676p.

SSP: Citigroup upgrades to neutral with a target price of 1,554p.

3i Group: Credit Suisse reiterates outperform with a target price of 1,420p.

Hyve Group: Liberum upgrades to buy with a target price of 140p.

Mears Group: Liberum reiterates hold with a target price of 190p.

Related Shares

More News
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

16 Apr 2024 09:30

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company rep...

16 Apr 2024 08:39

AstraZeneca's hails Imfinzi survival data on cancer form

(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract c...

12 Apr 2024 12:55

EU regulator rules out link between weight-loss drugs and suicidal thoughts

April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugel...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.